A New Perspective on Cannabis Equity Valuation
When it comes to valuing cannabis companies, analysts often face a variety of strategies. Among these, Discounted Cash Flow Analysis, Public Company Comparables, and M&A Precedent Transactions are typical methods. These approaches can apply to both small private entities and larger public corporations with differing complexities.
The Challenge of Distressed Valuation
Valuing distressed companies poses unique challenges, especially when current asset value hovers around or below total debt. The companies presented in our charts exhibit a total liabilities to market cap ratio exceeding 9x, indicating significant financial distress. Remarkably, except for Cannabist (CBSTF), our initial estimated asset values for these companies fall beneath their debt levels.
Understanding Equity Worth in Distress
This raises a vital question: Does a negative asset value lead to worthless equity? Not necessarily. Financial principles suggest that equity can be seen as a call option on asset values, with the debt acting as the strike price. If asset values surpass the debt amount, equity holders can liquidate assets for profit. Conversely, if asset values remain lower, equity holders have the choice to relinquish their interests without further liabilities, provided the option duration has not expired.
Establishing Asset Value and Option Life
Determining the current asset worth is crucial and can be approached through a few metrics. We apply a maximum valuation of 1x sales and a liquidation value at 1x tangible assets. While these figures may seem conservative, they reflect the considerable credit risk associated with distressed cannabis equities. Furthermore, the option’s life span corresponds to the weighted average maturity of the debt, assigning a one-year duration for companies with current liabilities.
The Role of Volatility in Valuation
Volatility is another critical factor in any option valuation model. For our assessment, we adopted a volatility rate of 30%, which aligns with conservative estimates for equity call options embedded in convertible debts or warrants. This figure is lower than many observed equity volatilities, yet it accounts for the challenges and costs related to shorting cannabis stocks, providing a reasonable estimate of asset volatility.
Valuation Models at Play
The Black-Scholes model serves as our chosen methodology for valuation due to the likelihood that none of these companies will distribute dividends shortly. In our analysis, we observe several companies such as Slang (SLGWF), Statehouse (STHZF), and Tilt (TLLTF) actively engaged in asset liquidation processes. On the other hand, companies like AYR (AYRWF), Cannabist (CBSTF), Gold Flora (GRAM), and Schwazze are not currently restructuring, although financial metrics suggest that they are facing distress.
Insights from Market Trends
An interesting revelation from our options valuation exercise is that six of the eleven companies have option valuations below their current market caps, while five show significantly higher valuations. This disparity offers investors a broad spectrum of potential outcomes.
Perception of Volatility
While volatility can often be perceived negatively, it’s essential to recognize that investors in distressed cannabis equities may still possess two invaluable assets that traditional metrics overlook: time and hope. With numerous catalysts for positive developments just around the corner, employing option valuation techniques becomes particularly relevant for higher-risk equities.
The Viridian Capital Chart of the Week
This weekly chart emphasizes crucial investment, valuation, and M&A trends derived from the Viridian Cannabis Deal Tracker, an invaluable resource for cannabis industry stakeholders.
Conclusion
Since its launch in 2015, the Viridian Cannabis Deal Tracker has been instrumental in monitoring capital raises and M&A activities within the legal cannabis, CBD, and psychedelics sectors, documenting over 2,500 capital raises and 1,000 M&A transactions with an impressive aggregate value exceeding $50 billion. Understanding these metrics allows investors and companies to make informed decisions in a dynamic and rapidly evolving market.
Frequently Asked Questions
What is the main focus of the article?
The article discusses innovative methods for evaluating distressed cannabis companies, emphasizing option-based valuation techniques.
Which companies are mentioned in distress?
Companies like Slang (SLGWF), Statehouse (STHZF), Tilt (TLLTF), AYR (AYRWF), and Cannabist (CBSTF) are highlighted regarding their financial status.
What valuation model is used for distressed companies?
The Black-Scholes model is employed due to its effectiveness in assessing companies unlikely to pay dividends soon.
Why is volatility significant in equity valuation?
Volatility impacts the option pricing, influencing potential valuation outcomes for distressed equities, reflecting market uncertainty.
How does the Viridian Cannabis Deal Tracker assist investors?
The Tracker provides comprehensive data on capital raises and M&A activities, aiding stakeholders in making informed investment decisions.
